Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
26-week randomized open-label trial of insulin detemir added to sitagliptin + metformin versus sitagliptin + metformin ± sulfonylurea in type 2 diabetes
2008-001050-40Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jul 2008; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-001050-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001050-40.